It must be noted that alternative cell lines, including colorectal cancer (CRC)-specific cell lines, could also be tested in the proposed assay to evaluate the targeting efficacy of CEA TCBs in various tumor types. This evidence concerns the gene CEACAM5 and colorectal cancer.